Resmed's market cap is currently $40.18B. The company's EPS TTM is $2.55; its P/E ratio is 28.86; and it has a dividend yield of 0.79%. Resmed is scheduled to report earnings on July 31, 2025, and the estimated EPS forecast is $2.52. See an overview of income statement, balance sheet, and cash flow financials.
